3285 results about "Biomedical technology" patented technology

The invention relates to the technical field of biological medicines, and discloses a high-activity lactobacillus rhamnosus probiotic microcapsule, which comprises the following components in parts by weight: lactobacillus rhamnosus: each gram of formula contains 1010 CFU; bifidobacterium: each gram of the formula contains 109 CFU; 10% to 20% of sodium alginate; 5%-15% of chitosan; 3%-8% of hydroxypropyl methyl cellulose; 3%-7% of pectin; 5% to 10% of fructo-oligosaccharide; 5%-10% of inulin; 0.1%-0.5% of vitamin C; and 0.1%-0.3% of vitamin E. Through double-layer and three-layer embedding technologies (such as compound use of sodium alginate and chitosan and compound use of pectin and gelatin), the tolerance of the probiotics in gastric acid and bile environments is remarkably improved, the probiotics are effectively protected through a multi-layer embedding structure, the survival rate of the probiotics in the gastric environment reaches up to 90%, and the release rate in the small intestine exceeds 75%.

The invention relates to the technical field of biomedicine, in particular to an internet-of-things-based digitized management method for graded nursing of an intensive care unit. The method comprises the following steps that heterogeneous data of a patient are collected in real time through nursing monitoring equipment, and a principle physiological data flow is obtained; performing comprehensive physiological index calculation on the principle physiological data flow to obtain a comprehensive physiological index; carrying out individualized physiological index prediction according to the comprehensive physiological index, and carrying out patient condition deterioration probability prediction to obtain condition deterioration probability data; performing nursing level demand prediction according to the individualized physiological index prediction result to obtain nursing level demand probability data; and performing illness state trend prediction vector generation on the illness state deterioration probability data and the nursing level demand probability data to obtain an illness state trend prediction vector. According to the invention, through more accurate illness state trend prediction and graded early warning, medical workers are better assisted to carry out graded nursing on patients, and the management level of an intensive care unit is improved.

The invention relates to the technical field of biomedicine, and discloses a female private rehabilitation training system integrating a breathing method and neural motor control, and the system comprises a data collection module which is used for collecting physiological data of a user; the personalized training scheme generation module is used for generating a personalized nerve-muscle-fascia training scheme; the nerve-muscle synchronous resonance training module is used for constructing a time sequence matching model and generating an adaptive training dynamic control instruction; the space-time adaptability training module is used for adjusting training duration, intensity and stimulation frequency; the multi-dimensional nerve-muscle feedback fusion module is used for constructing a feedback response model; and the fascia synchronous activation and relaxation module is used for coordinating the tension relationship between the fascia and the muscle system. According to the method, feature matching is carried out on an electric activation heat map matrix through the convolutional neural network, analysis of a myoelectricity response state transition probability is carried out in combination with a hidden Markov model, and stimulation parameters and respiratory rhythm are optimized in real time according to a training process.

The invention discloses development, preparation and application of a carbapenemase immunochromatography kit, and belongs to the technical field of biological medicines. According to comparison of amino acid sequences of five common carbapenemase variants of KPC, IMP, NDM, VIM and OXA48 types, the immunogen is prepared from conserved epitope sequences obtained respectively. A mouse is immunized, and a specific antibody pair which is strong in affinity and can be combined with multiple variants is obtained through multi-platform screening. On the basis, the carbapenemase quintuplet detection kit is developed by utilizing an immunochromatography method, has the advantages of high sensitivity, good specificity, capability of covering various drug-resistant variants, capability of detecting multiple targets at one time and rapidness and convenience in detection, and provides important help for clinical auxiliary diagnosis and medication guidance.

The present invention relates to the field of biomedicine technology, specifically a preparation method of a silk fibroin hyaluronic acid filler for injection. The present invention concentrates a silk fibroin solution to obtain a concentrated silk fibroin solution, and then dilutes it to obtain a diluted silk fibroin solution; the diluted silk fibroin solution is heated to form a silk fibroin gel, granulated to obtain silk fibroin gel particles; 1,4-butanediol diglycidyl ether and a sodium hydroxide solution are mixed uniformly, hyaluronic acid and 1 / 3 of the mass fraction of hydroxyapatite are added, after stirring uniformly, swelling, purification and granulation are carried out, and the remaining mass fraction of hydroxyapatite is added to obtain composite gel particles; the composite gel particles and the silk fibroin gel particles are mixed uniformly, added to the gel to mix, and a silk fibroin hyaluronic acid filler is obtained, which effectively prolongs its degradation time.

The invention discloses a CA9-targeted chimeric antigen receptor and application thereof, and belongs to the technical field of biological medicines. The CA9 targeting chimeric antigen receptor provided by the invention comprises a CD8 alpha leading signal peptide, an anti-CA9 single-chain variable fragment, a CD8 alpha hinge, a CD8 transmembrane structural domain and a CD3 zeta intracellular costimulatory signal transduction structural domain. According to the invention, an anti-CA9 single-chain variable fragment is used as an antigen binding structural domain to construct a chimeric antigen receptor (CAR) molecule, the macrophage expressing the anti-CA9CAR can realize specific targeting and phagocytosis killing of CA9 positive kidney cancer cells, and the constructed lipid nanoparticle delivery system can effectively transfer a gene expression vector, so that the gene expression vector can realize effective target site delivery, and the CA9 positive kidney cancer cells can be effectively targeted and killed. The constructed hydrogel-liposome combined drug delivery system has the performance of relieving toxic and side effects, controllable release and hemostasis.

The invention relates to the technical field of biomedicine, in particular to a hepatic cell differentiation degree evaluation method based on multi-omics data, which comprises the steps of sample collection and preprocessing, transcriptomics, proteomics and metabonomics data analysis, multi-omics data integration and modeling and result output. By integrating multi-level biological information, a multi-dimensional scoring model is constructed, the liver cell differentiation state is quantitatively evaluated, and a standardized grading system is provided for clinic. The method can solve the limitation of single omics analysis, improves the evaluation accuracy and reliability, has universality, can be popularized to other malignant tumor research, and assists precise medical development.

The invention discloses a nano system for tumor radioimmunotherapy and a preparation method and application thereof, and belongs to the technical field of biological medicines.The system modifies bacteria outer membrane vesicles (OMVs) through engineering to enable the bacteria outer membrane vesicles to carry magnetite nanoparticles (Fe3O4NPs) and an ATR inhibitor VE822, the Fenton reaction activity of the Fe3O4NPs and the synergistic effect of the ATR inhibitor for inhibiting DNA damage repair are utilized, and the tumor radioimmunotherapy effect is improved. DNA damage is amplified, DNA damage reaction (DDR) is inhibited, generation of hydroxyl radicals (. OH) under radiation is enhanced, radiation resistance of tumor cells is reduced, immune reaction is reactivated, infiltration of effector T cells to tumors is improved, growth of mice tumors is remarkably inhibited, and an effective strategy is provided for tumor radioimmunotherapy.

The invention belongs to the technical field of molecular biomedicine, and provides a colorectal cancer early screening method based on multi-omics sequencing, which comprises the following steps: collecting a plasma sample to be detected, collecting sequencing data to be detected, and classifying a colorectal tumor early screening model. The training process of the colorectal tumor early screening model comprises the steps of original sequencing data acquisition, quality control and human reference genome comparison, reference methylation data acquisition, tumor specific region screening, plasma cfDNA sequencing data acquisition, coordinate determination sequencing data acquisition, methylation feature set screening and terminal motif feature screening. And carrying out breakpoint motif feature screening, feature merging and model training. By constructing the colorectal tumor early screening model, the non-invasive colorectal cancer detection method with high cost effectiveness is realized, the economic cost of sequencing is reduced, and the accuracy and sensitivity of detection are remarkably improved.

The invention relates to the technical field of artificial intelligence and biomedicine, and provides a multi-agent diagnosis planning device and method based on a consultation thinking process. The multi-agent diagnosis planning device comprises a diagnosis planning agent, a pathological section analysis agent, an in-hospital information aggregation agent, an information search agent, a knowledge base search agent, an evaluation agent, an arbitration agent and a risk assessment agent. Each agent realizes data interaction through a dynamic priority message bus, and the evaluation agent and the arbitration agent form a progressive verification closed loop: after the evaluation agent outputs a question evidence chain, the arbitration agent triggers diagnosis correction only when question items are greater than 3 items, and otherwise, final diagnosis is output based on a preset rule. According to the invention, the thinking process of multidisciplinary expert collaboration in clinical consultation is simulated by constructing a multi-agent collaborative diagnosis framework, and the whole process intelligence from medical data acquisition and analysis to diagnosis decision is realized.

The invention relates to the technical field of biological medicine, and discloses a pharmaceutical composition of paclitaxel dimer prodrug nanoparticles and a traditional Chinese medicine compound and application of the pharmaceutical composition, and the pharmaceutical composition is composed of Qiyuansanlong prescription freeze-dried powder and paclitaxel dimer prodrug nanoparticles; wherein the paclitaxel dimer prodrug nanoparticles comprise one of NQO1 response type PTX dimer prodrug nanoparticles (PTX-Q-PTX NPs) or GSH (glutathione) response type PTX dimer prodrug nanoparticles (PTX-SeSe-PTXNPs), and the paclitaxel dimer prodrug nanoparticles comprise one of NQO1 response type PTX dimer prodrug nanoparticles (PTX-Q-PTX NPs) and GSH response type PTX dimer prodrug nanoparticles (PTX-SeSe-PTXNPs). According to the pharmaceutical composition disclosed by the invention, a traditional Chinese and western medicine synergistic treatment system is innovatively constructed, and the advantage of multi-dimensional synergistic interaction is shown. Firstly, an NQO1 / GSH double-response type intelligent release system is adopted, and a biomarker highly expressed by tumor tissue can be specifically responded to realize precise drug release, so that the PTX concentration in tumors is improved compared with that of a traditional dosage form, and meanwhile, the drug circulation time is prolonged. Secondly, the active ingredients in the Qiyuansanlong prescription freeze-dried powder can significantly down-regulate the PD-L1 expression level, synergistically enhance CD4 + T and CD8 + T cell infiltration, and form chemical-immune dual killing effects.

The invention discloses a medicinal and edible composition for treating dysmenorrhea and application of the medicinal and edible composition, and belongs to the technical field of biological medicines. The medicinal and edible composition is prepared from the following components in parts by weight: 10 to 20 parts of radix astragali seu hedysari, 10 to 20 parts of fructus foeniculi, 7 to 15 parts of radix angelicae sinensis, 7 to 15 parts of herba cistanche, 7 to 15 parts of radix linderae, 7 to 15 parts of fructus lycii, 3 to 10 parts of rhizoma chuanxiong, 3 to 10 parts of cortex cinnamomi, 3 to 10 parts of rhizoma zingiberis, 3 to 10 parts of radix glycyrrhizae preparata, 3 to 10 parts of rhizoma cyperi and 3 to 10 parts of rhizoma corydalis. The components in the medicinal and edible composition can relax channels and relieve pain and relieve pain caused by uterine contraction or uterine spasm, the adopted raw materials are all medicinal and edible, and compared with western medicines, the medicinal and edible composition has no side effect.

The invention provides an IBS micro-ecological transplantation intelligent prediction method and system based on multi-omics driving, and relates to the technical field of biomedicine. The method comprises the following steps: establishing a multi-omics data fusion subsystem to collect metagenome, metabolome, host genome and clinical phenotype group data of a target patient; inputting the data into a flora-metabolite combined network analysis model to construct an interaction network and extracting features; generating an incidence matrix based on the features and the host genome data and calculating indexes; generating indexes through a dynamic response algorithm in combination with the clinical phenotypic data and the indexes; and outputting a curative effect prediction result by using a transfer learning framework combined with modeling. The system comprises a data acquisition module, a network analysis module, a correlation calculation module, a dynamic response module and a joint modeling module. According to the method, multiple omics data are integrated, the flora and host relation is accurately mined, intelligent prediction of the micro-ecological transplantation curative effect is achieved, powerful support is provided for IBS personalized treatment, and meanwhile data processing and safety guarantee measures are taken.

The invention discloses application of an RNF130 activator in preparation of a medicine for preventing and / or treating acute kidney injury, and belongs to the technical field of biological medicine. The invention provides an application of an RNF130 activator in preparation of a medicine for preventing or treating renal ischemia-reperfusion injury, the RNF130 activator can improve the renal function of a mouse suffering from renal ischemia-reperfusion injury, improve the levels of serum creatinine, urea nitrogen and cystatin C, reduce the levels of kidney injury markers KIM-1 and LCN2, reduce renal tubule injury, improve the renal function of the mouse suffering from renal ischemia-reperfusion injury, improve the renal function of the mouse suffering from renal ischemia-reperfusion injury and improve the renal function of the mouse suffering from renal ischemia-reperfusion injury and the renal function of the mouse suffering from renal ischemia-reperfusion injury. Therefore, the compound plays a role in preventing and treating the kidney ischemia reperfusion injury, and a new target is provided for preparing the medicine for preventing and treating the acute kidney injury.

The invention relates to the technical field of biological medicine, in particular to a dynamic fermentation tank control system for producing a diabetes intestinal microecological regulating preparation. The system comprises a fermentation tank sensing feedback control network establishment module, a fermentation tank growth earlier-stage nutrition supply control module, a fermentation tank growth later-stage adjustment control module and a fermentation tank metabolism process environmental condition control module, and can generate an embedded sensing feedback control network by installing a sensor and being connected with a central feedback control system. The sugar source supply quantity, the nitrogen source supply quantity, the temperature, the pH value, the dissolved oxygen concentration and the oxygen and carbon dioxide gas proportional flow corresponding to the fermentation tank are synchronously monitored in real time, so that supply cooperative dynamic control and fermentation growth cooperative dynamic control are carried out, and meanwhile, metabolism environment condition cooperative dynamic control is carried out; therefore, the cooperative control work of the microbial growth environment conditions is executed. By optimizing environment control in the fermentation process, efficient production of the intestinal microecology regulating preparation can be achieved.

The invention belongs to the technical field of biological medicines, and particularly relates to hydrogel with photo-thermal multiple antibacterial and hemostatic functions. The multifunctional hydrogel is prepared from epsilon-polylysine (EPL), gallic acid (GA), tannic acid (TA) and ferric trichloride hexahydrate. The polyphenols are obtained through multiple mechanisms such as reaction between the polyphenols and amino groups, metal chelation, pi-pi interaction and electrostatic attraction (as shown in Figure 1). The metal ion and multiple dynamic cross-linking system hydrogel is constructed, the hydrogel with positive charges enriched on the surface can act with blood platelets with negative charges, red blood cell aggregation, blood platelet adhesion and vasoconstriction effects are promoted, and the blood coagulation efficiency is improved. The hydrogel shows excellent antibacterial performance and photo-thermal performance, can prevent infection in the inflammation stage of wound healing, can effectively accelerate wound healing, and has good biological safety.

The invention relates to the technical field of biological medicine, in particular to a wound repair material and a preparation method and application thereof.The wound repair material is in a gel shape and comprises hydrogel and platelet-rich plasma, the hydrogel is formed by dynamic crosslinking of collagen and oxidized hyaluronic acid, and the hydrogel physically encapsulates the platelet-rich plasma. The gelatinous wound repair material provides bionic mechanical support through a dynamic cross-linked network, synergistically regulates and controls an inflammation microenvironment and sequential release of PRP growth factors, remarkably promotes angiogenesis and wound healing, is suitable for the clinical treatment fields of diabetic ulcer, chronic difficult-to-heal wounds and the like, and has broad application prospects. The material has the functions of mechanical support, anti-inflammatory regulation and growth factor controlled release.

The invention provides multifunctional hydrogel, drug-loaded hydrogel as well as a preparation method and application of the multifunctional hydrogel and the drug-loaded hydrogel, and belongs to the technical field of biological medicines. According to the multifunctional hydrogel provided by the invention, the gelatin, the transglutaminase and the sulfhydrylated hyaluronic acid are used as preparation raw materials, so that the problem of limited performance of a hydrogel product in the prior art is solved. According to the hydrogel product prepared by the invention, cell adhesion can be provided through a transglutaminase cross-linked gelatin network, meanwhile, an ROS removal effect is provided through a dynamic disulfide bond cross-linked hyaluronic acid network, and degradation of the hydrogel can be regulated and controlled through combination of the two networks; according to the drug-loaded hydrogel provided by the invention, the exosome derived from neural stem cells is additionally encapsulated in the hydrogel, the exosome and the hydrogel jointly achieve the effects of enhancing inhibition of glial scars and resisting inflammation, and the material provided by the invention can promote repair and regeneration of neurons and myelin sheaths, so that the drug-loaded hydrogel can be used for preparing cerebral hemorrhage treatment drugs and can be used for preparing drugs for treating cerebral hemorrhage. And an effective means is provided for the treatment of related diseases.

The invention belongs to the technical field of biological medicines, and particularly relates to application of secretory lactase-like protein (LCTL) as a diagnostic marker in preparation of a diagnostic kit for chronic kidney diseases. According to the present invention, the secretory form of the LCTL is found for the first time, the secretory LCTL content in the human serum is detected by using the existing commercial ELISA kit for the first time, and the further research finds that the secretory LCTL content in the serum of the chronic kidney disease patient is significantly reduced compared with the normal person; and the content of the LCTL in the serum is obviously related to the renal function impairment degree and proteinuria degree of the patient, so that the application of the secretory LCTL in preparing the biomarker for diagnosing the chronic kidney disease is provided for the first time. The invention provides a new method for chronic kidney disease diagnosis, and has important clinical significance and commercial value.

The invention relates to the technical field of biomedical treatment, and particularly discloses a biological valve treatment method and a biological valve dry piece. The bioprosthetic valve treatment method provided by the invention comprises the following steps: pretreatment, crosslinking, degreasing, anti-calcification and drying. In the anti-calcification step, an anti-calcification solution is used for treatment; the anti-calcification solution is a 0.08 to 0.12 M PBS (Phosphate Buffer Solution) containing 0.5 to 6 weight percent of ethanolamine and 0.1 to 0.5 weight percent of sodium borohydride; furthermore, the anti-calcification solution is a 0.08 to 0.12 M PBS (Phosphate Buffer Solution) containing 2 to 4 weight percent of ethanolamine and 0.2 to 0.4 weight percent of sodium borohydride; the invention further provides the bioprosthetic valve dry piece obtained through the bioprosthetic valve processing method. According to the bioprosthetic valve treatment method, the anti-calcification performance of the bioprosthetic valve can be improved, and the obtained bioprosthetic valve dry piece has good stability and storage performance.

The invention discloses a risk early warning system based on enteral nutrition management of a patient, and belongs to the technical field of medical technology and biomedicine. A risk early warning system based on enteral nutrition management of a patient comprises a patient monitoring module, a score calculation module, a nutrition control module, an early warning notification module, a nutrition scheme adjustment module and a continuous observation and feedback module. The problems that in the prior art, symptoms of critical patients with the acute respiratory distress syndrome are not monitored in time, the regulation efficiency of enteral nutrition supply is low, errors are prone to occurring, and an early warning mechanism is incomplete are solved. By introducing a real-time monitoring and intelligent quantitative evaluation tool, an automatic regulation and control mechanism and multi-level early warning notification and detailed guidance, main problems existing in enteral nutrition management of the severe patient with the acute respiratory distress syndrome at present are effectively solved, and the rehabilitation process and the treatment effect of the patient are remarkably improved.

The present invention discloses a nano antibody against BCMA and its preparation method and application, and relates to the field of biomedical technology. The present invention uses CRISPR / Cas9 technology to knock out B2M and TRAC genes in T cells to prepare universal CAR-T cells; the nano antibody targeting BCMA and the natural ligand SIRPα extracellular N-terminal V region of CD47, the transmembrane region of CD28, the intracellular signal region of 4-1BB and the intracellular signal region of CD3ζ are connected in series to form a dual-targeted chimeric antigen receptor for the treatment of multiple myeloma, so as to solve the high recurrence problem faced by CAR-T cell therapy in the treatment of multiple myeloma. The universal CAR-T cells prepared by the present invention have strong killing activity against multiple myeloma cells, effectively improve the treatment effect, and provide a key material for the subsequent development of adoptive immunotherapy with high efficiency and lasting anti-tumor activity.

The invention discloses a spirulina platense skin extract as well as a preparation method and application thereof, and relates to the technical field of biomedicine. The obscured spirulina skin extract is rich in various active ingredients including collagen family members, viscose protein, C1Q complement protein, fibronectin and the like, and the ingredients complement and promote one another, so that the extract has remarkable effects in the aspects of skin aging resistance, skin injury repair and the like; therefore, the method has a wide application prospect in medicine research and development, cosmetics and functional foods. According to the extraction method of the skin protein of the obtuse spirulina, the sample is subjected to rapid freeze thawing treatment, and the steps of mechanical crushing, ultrasonic-assisted separation and multiple filtration are combined, so that the influence on the activity of the product is avoided, and various compound proteins can be obtained; the pH value of a buffer solution is adjusted, the property of the extract is further optimized, and the extract is more suitable for human skin, is sterile and can be directly used as a product raw material, so that large-scale production is realized, and industrial application of the obtuse spirulina skin extract is promoted.

The invention discloses a macrocyclic covalent organic polymer material for inhibiting a pi-pi stacking effect and application of the macrocyclic covalent organic polymer material, and belongs to the technical field of biological medicines. The preparation method comprises the following steps: adding 5, 10, 15, 20-tetra (4-ethynylphenyl) copper porphyrin and a macrocyclic monomer into an organic solvent in a protective atmosphere, and carrying out solvothermal reaction in the presence of a catalyst and alkali to obtain the macrocyclic covalent organic polymer material. According to the invention, 5, 10, 15, 20-tetra (4-ethynylphenyl) copper porphyrin and a macrocyclic monomer form a porous polymer MCP-CU-POP, the material utilizes the photo-thermal capability to combine the effects of simulated photo-thermal (PTT), photodynamic (PDT), peroxidase (PODs) and glutathione peroxidase (GSH-Px) to perform synergistic antibiosis, and the inherent characteristics of an infected microenvironment can also be utilized to induce death of bacteria, so that the antibacterial property of the material is greatly improved, and the antibacterial property of the material is greatly improved. And the microenvironment of the bacterial infection part can be adjusted, so that the recovery of the bacterial infection wound can be obviously accelerated.

The invention belongs to the technical field of biological medicine, and particularly relates to application of polypeptide in treatment of psoriasis. The amino acid sequence of the polypeptide provided by the invention is SEQ ID NO.1, so that the spleen-body ratio of a psoriasis mouse can be effectively reduced, and the inflammation level in the body can be reduced; the epidermal thickness of psoriasis mice and inflammatory factors in skin lesion tissues can be remarkably reduced, keratinocyte proliferation is reduced, and inflammatory factors released by inflammatory cells recruited to skin lesion positions are reduced. The polypeptide provided by the invention shows certain advantages in the aspects of relieving inflammatory response, promoting tissue repair and the like when being used for treating psoriasis. The invention provides a new method and means for treating psoriasis, and promotes the progress and development of medicine.

The invention relates to the technical field of biomedicine, in particular to a time interference dynamic multi-target accurate focusing transcranial electric therapeutic instrument which comprises a host module, an electric stimulation module, an intelligent stimulation mode optimization coordination module, an integrated electrode module, an electroencephalogram processing module, an adaptive treatment navigation module based on fMRI + EEG and a safety protection module. The navigation module calculates fMRI and EEG information, generates and optimizes a stimulation mode, the host module overall controls all the modules, the electrical stimulation module outputs multiple paths of high-frequency interference signals and low-frequency compensation signals, the integrated electrode module achieves stimulation and electroencephalogram collection in a time-sharing mode, the electroencephalogram processing module collects and processes the signals, and the safety protection module guarantees treatment safety. According to the application, the bottleneck that the current utilization rate is low, the positioning is fuzzy and the mode is rigid in the existing transcranial electrical stimulation technology is broken through, accurate synchronous / sequential stimulation of multiple deep brain regions is realized, and the accuracy, effectiveness and safety of treatment of neurological and mental diseases are improved.

The invention discloses a natural product-based nano antioxidant for treating acute pancreatitis and a preparation method of the natural product-based nano antioxidant, and relates to the technical field of biological medicines. 25 mg of ferulic acid (FA); and 15 mL of 80% (v / v) ethanol-deionized water solution. According to the natural product-based nano antioxidant for treating acute pancreatitis and the preparation method thereof, the nano antioxidant effectively targets inflammatory pancreatic tissues through the specific interaction of chondroitin sulfate (CS) and CD44, and is split and released under the stimulation of pH / GSH and H2O2 in cells to generate FA and zein degradation products, the FA and zein degradation products efficiently play a synergistic role in removing ROS, and the natural product-based nano antioxidant can be used for treating acute pancreatitis. Therefore, inflammation is relieved; the nano antioxidant shows an excellent in-vivo treatment effect on acute pancreatitis and has a clinical application prospect.

The present application belongs to the field of biomedicine technology, and specifically relates to a chondroitin sulfate oligosaccharide derivative and a preparation method and application thereof. The structure of the chondroitin sulfate oligosaccharide derivative is shown in Formula I, #imgabs0#Formula I, where R1 is SO3H, R2 is H or R1 is H, R2 is SO3H, and the polymerization degree of the chondroitin sulfate oligosaccharide derivative is equal to 8; the chondroitin sulfate oligosaccharide derivative has good promotion of chronic hepatitis repair and anti-inflammatory activity, and has a clear structure, and can be used for oral treatment of non-alcoholic fatty liver disease.

The invention relates to the technical field of biomedicine, in particular to a gestational period premature delivery risk auxiliary prediction method and system, and the method comprises the steps: obtaining the historical body data and delivery cycle of a pregnant woman, and determining the historical premature delivery degree of the pregnant woman according to the delivery cycle; according to the premature delivery degree difference between different historical pregnant women and the deviation degree change condition difference of the same type of body data during each physical examination, determining the premature delivery correlation degree of different types of body data of the historical pregnant women; clustering the historical pregnant women according to the deviation time difference of the same type of body data among different historical pregnant women, determining the overall correlation of each type of body data according to the number of pregnant women in the cluster and the premature delivery correlation degree of the corresponding type of body data, and screening out the target type of body data; and based on the body data of the target type of the historical pregnant woman during different times of physical examination, constructing a premature delivery prediction model to perform premature delivery prediction. According to the method, the accuracy of premature delivery prediction is effectively improved.